Bausch Health Companies Inc. , a global, diversified pharmaceutical company, and Solta Medical, a global leader in medical aesthetics, today announced the launch of the Clear + Brilliant® Touch laser ...

Elastic parametric response mapping (ePRM), a CT-based severity scoring system for regional lung volumes, can monitor COPD progression.

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Use of race-based reference equations in pulmonary function testing has led to thresholds for what qualifies as impairment in populations.

Almost 30,000 people in England with chronic obstructive pulmonary disease (COPD) could soon have access to a biologic treatment, Sanofi and Regeneron's Dupixent, after it was recommended for use by ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.

Before this procedure, John Kelly was told he didn't have long to live because of his scleroderma condition.

Getting dressed is one of the morning rituals columnist Caroline Gainer observes to remind herself that she is more than her disease.

The U.S. Food and Drug Administration said on Thursday it approved Boehringer Ingelheim's drug for patients with a type of advanced lung cancer who have received prior treatment, marking the second ...